Johnson & Johnson faces legal pressures from talc lawsuits, likely to create persisting growth and valuation headwinds. Read ...

The speaker’s struggle to bring his party’s sprawling domestic policy bill in for a landing was just the latest in his string ...

A federal court denied Johnson & Johnson's motion to implement a 340B drug rebate model, siding with HHS and hospitals who ...